- First-line bevacizumab combined with reduced dose interferon-alpha 2a is active in patients with metastatic renal cell carcinoma2008 | First Faculty of Medicine
- Interferon alpha in treatment of CML patients - resultsPublication without faculty affiliation
- Serum levels of interferon alpha do not correlate with disease activity in patients with dermatomyositis/polymyositis2011 | First Faculty of Medicine
- Interferon - alpha: A Key Factor in Autoimmune Disease?2006 | First Faculty of Medicine
- Interferon - alpha: A Key Factor in Autoimmune Disease?2006 | Faculty of Physical Education and Sport
- Interferon alpha in the treatment for advanced renal cell carcinoma2006 | Faculty of Medicine in Hradec Králové
- Decreased dendritic cell numbers but increased TLR9-mediated interferon-alpha production in first degree relatives of type 1 diabetes patients2014 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Efficacy of induction monotherapy with interferon-alpha in chronic viral hepatitis C2001 | First Faculty of Medicine
- Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis2007 | First Faculty of Medicine
- Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis2007 | Faculty of Physical Education and Sport
- Malignant melanoma succesfully treated by interferon alphaPublication without faculty affiliation
- Is there any relation between Myastenic disorders and interferon - alpha/beta therapy?Publication without faculty affiliation
- Is there any relation between Myasthenic disorders and interferon - alpha/beta therapy?Publication without faculty affiliation
- Hairy cell leukaemia therapy (HCL) with interferon alpha1994 | First Faculty of Medicine
- First-line bevacizumab combined with reduced dose interferon-alpha 2a is active in patients with metastatic renal cell carcinoma +12008 | Faculty of Medicine in Hradec Králové
- Interferon Alpha Treatment for Sight Threatening Posterior Uveitis - New ExperiencesPublication without faculty affiliation
- Recombinant interferon alpha in local treatment of metastatic renal cell carcinomaPublication without faculty affiliation
- Investigation of factor VIII inhibitor in patients with haemophilia A during interferon-alpha therapyPublication without faculty affiliation
- Occurrence of thyrotoxicosis during the therapy of mixed chronic active hepatitis B and C by therapy with interferon alphaPublication without faculty affiliation
- Why is the Response to Combination Therapy with Interferon Alpha 2b and Ribavirin in Chronic Hepatitic so Poor2002 | First Faculty of Medicine
- Thyrotoxicosis due to long - term therapy with Interferon alpha in the patient with mixed chronic active hepatitis B and C1999 | Faculty of Medicine in Hradec Králové
- Treatment of Peyronie´s disease by local application of interferon-alpha 2b - our experiences in 19 patientsPublication without faculty affiliation
- Local application of interferon-alpha 2B in treatment of Peyronie´s disease: our experience in 19 patientsPublication without faculty affiliation
- High-dose Interferon Alpha in Treatment of Patients with Malignant Melanoma, Monitoring of Predictive and Prognostic Biomarkers2011 | Faculty of Medicine in Hradec Králové
- First results combined intravesical therapy with BCG vaccine and interferon alpha 2b in recurrent superficial bladder tumorPublication without faculty affiliation
- Immunotherapeutic options for treatment of malignant melanoma2019 | First Faculty of Medicine
- Efficacy of Sunitinib in Elderly Patients with Metastatic Renal Cell Carcinoma: Data from Real-World Clinical Practice2016 | First Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Medicine in Pilsen
- Interferon-alpha Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients2016 | First Faculty of Medicine, Faculty of Science, Third Faculty of Medicine
- Current role of cytokine medication in the treatment of renal cell carcinoma2010 | Faculty of Medicine in Hradec Králové